区域麻醉与患有充血性心力衰竭的患者的改善死亡率和发病率有关,这些患者经历了下肢截肢
Mohamad Chahrour1, Hassan Chamseddine2, Loay Kabbani2
1Division of Vascular Surgery, Department of Surgery, University of Iowa Hospital and Clinics, Iowa, IA.
在患有充血性心力衰竭 (CHF) 的患者中,用于下肢截肢 (LEA) 的区域麻醉 (RA) 与全身麻醉 (GA) 相比,与更好的结果有关. 这项研究表明,RA可能会降低这一高风险群体的死亡率和并发症.
科学领域:
- 麻醉学 麻醉学
- 心脏病学 心脏病学
- 外科手术的结果
背景情况:
- 文献显示,在下肢截肢 (LEA) 中,全身麻醉 (GA) 与区域麻醉 (RA) 的结果各不相同.
- RA 对经过 LEA 的充血性心力衰竭 (CHF) 患者的影响仍然未被探索.
- 这项研究调查了麻醉对接受LEA的CHF患者结果的作用.
研究的目的:
- 为了确定麻醉选择是否会影响经过LEA的CHF患者的结果.
- 为了比较GA和RA对这一特定患者群体的发病率和死亡率的影响.
主要方法:
- 利用美国外科医生学院国家外科质量改进计划数据库 (2005-2022).
- 确定了接受LEA的CHF患者,并比较了接受GA与RA的患者.
- 采用多变量逻辑回归来分析麻醉类型与30天术后结果之间的关联.
主要成果:
- 包括5,831名患者 (4,779名GA,1,052名RA).
- 与GA相比,RA与明显较低的死亡率 (aOR 0.79),肺炎 (aOR 0.76),败血症休克 (aOR 0.64),需要输血 (aOR 0.82) 和30天再入院 (aOR 0.79) 相关.
- 这些发现根据患者的特征进行了调整.
结论:
- 与全身麻醉相比,LEA的区域麻醉在CHF患者中与降低的发病率和死亡率有关.
- 在可行的情况下,应考虑对接受LEA的CHF患者进行RA.
- 需要进一步的研究来证实这些发现.
更多相关视频
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
03:53Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
Published on: March 15, 2024
相关概念视频
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Local Anesthetics: Clinical Application as Spinal Anesthesia
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
